A hormone produced in the gut, FGF19, has been shown to act directly on the brain to boost energy expenditure, burn fat and ...

Explore the exciting advancements in organoids with the successful growth of liver tissue that includes internal blood ...

Explore the latest research on Parkinson's and a key brain protein that may lead to new treatments for this common condition.

Explore innovative clinical trial design with digital twins, enhancing predictions while reducing costs and efforts in ...

Explore new therapeutic targets for leukaemia treatment discovered by researchers in Japan, focusing on acute myeloid ...

Explore the groundbreaking achievements in quantum as Kipu Quantum and IonQ solve a complex protein folding problem on ...

Explore the link between α2,6-sialyltransferase-I and Alzheimer's disease progression. Understand the new findings on ...

Drug discovery often pushes the boundaries of what we understand. John Lepore, MD, CEO of ProFound Therapeutics and CEO-Partner at Flagship Pioneering, is furthering that challenge by redefining where ...

Overcoming a key delivery challenge A long-standing challenge in using lipid nanoparticles (LNPs) is their tendency to accumulate in the liver, where they are filtered out by the reticuloendothelial ...

Scientists at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in collaboration with Dana-Farber Cancer Institute at Harvard Medical School, Columbia University ...

Justin Taylor, M.D., a physician-scientist at the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has found a promising therapeutic strategy for colorectal ...

DARPin therapeutics were a prominent theme at AACR 2025, with Molecular Partners presenting a trio of preclinical programmes spanning radiopharmaceuticals and immune cell engagers. DARPins – designed ...